![](/img/cover-not-exists.png)
PNS131 DO THE EVOLVING MARKET ACCESS POLICY DYNAMICS AND INCREASING IMPORTANCE OF CLINICAL AND HEALTH ECONOMIC EVIDENCE REPRESENT THE NEXT BIG OPPORTUNITY FOR PHARMA TO DEMONSTRATE VALUE IN CHINA?
Wang, A., Chalmers, M.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.2032
Date:
November, 2019
File:
PDF, 381 KB
2019